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Abstract  
This study investigated the effects of daily intraperitoneal injections of N-methyl-D-aspartate 
receptor antagonist MK-801 and nitric oxide synthase inhibitor nitro-L-arginine (L-NA) on the 
survival of retinal ganglion cells (RGCs) at 1 and 2 weeks after unilateral optic nerve transection in 
adult hamsters. The left optic nerves of all animals were transected intraorbitally 1 mm from the 
optic disc and RGCs were retrogradely labeled with Fluorogold before they received different daily 
dosages of single MK-801 or L-NA as well as daily combinational treatments of these two chemicals. 
All experimental and control animals survived for 1 or 2 weeks after optic nerve transection. Our 
results revealed that the mean numbers of surviving RGCs increased and then decreased when the 
dosage of MK-801 (1.0, 3.0 and 4.5 mg/kg) and L-NA (1.5, 3.0, 4.5 and 6.0 mg/kg) increased at both 
1 and 2 weeks survival time points. Daily combinational use of 1.0 mg/kg MK-801 and 1.5 mg/kg 
L-NA lead to a highest RGC number that was even higher than the sum of the RGC numbers in  
1.0 mg/kg MK-801 and 1.5 mg/kg L-NA subgroups at 2 weeks. These findings indicated that both 
MK-801 and L-NA can protect axotomized RGCs in a dose-dependent manner and combinational 
treatment of these chemicals possesses a potentiative and protective effect.  
Key Words: retinal ganglion cells; optic nerve transection; N-methyl-D-aspartate receptor; nitric 
oxide synthase; neuronal survival; hamster  
Abbreviations: RGCs, retinal ganglion cells; ON, optic nerve; NO, nitric oxide; NOS, nitric oxide 
synthase; NMDA, N-methyl-D-aspartate 
  
 
INTRODUCTION 
    
The excitatory amino acid glutamate is one 
of the major excitatory transmitters in the 
central nervous system, and its interactions 
with specific membrane receptors are 
responsible for many neurobiological 
functions. Glutamate has been implicated in 
delayed brain injury after cerebral ischemia 
and hypoglycemia, and traumatic brain 
injury also caused a marked elevation in 
extracellular glutamate adjacent to the 
trauma site. The effect of excitotoxic insult is 
caused by an increased formation of nitric 
oxide (NO)
[1-2]
 catalysed by nitric oxide 
synthase (NOS) which is induced by excess 
calcium influx via N-methyl-D-aspartate 
(NMDA) subtype of glutamate receptor 
operated channels. NO released from 
injured neurons results in a direct massive 
neuronal death
[3]
. The stimulation of 
glutamate receptors by excitatory amino 
acids and released NO has been linked to 
neuronal degeneration and toxicity. The 
selective non-competitive NMDA receptor 
antagonist dizocilpine maleate (MK-801) 
and the NOS inhibitor NG-nitro-L-arginine 
methyl ester (L-NAME) could exert 
neuroprotective actions in experimentally 
induced ischemia
[4-5]
. In the visual system, 
the excitotoxicity induced by glutamate has 
been thought to be one of the major reasons 
for the death of retinal ganglion cells (RGCs) 
caused by glaucoma and retinal ischemia. 
However, the effects of glutamate are not 
clear in traumatic optic nerve (ON) injury 
since activation/inactivation of retinal 
metabotropic glutamate receptors does not 
play an important role for the initiation and 
execution of secondary RGC loss after ON 
transection and NMDA lesion in the adult 
rat
[6]
. Whether NMDA antagonists can 
decrease RGC death remains 
controversial
[7-10]
, and effects of NO/NOS on 
the survival of axotomized RGCs are still 
inconclusive
[11-14]
. Moreover, no studies 
have ever been reported to examine 
dose-dependent and combined effects of a 
NMDA antagonist and NOS inhibitor on the  
www.nrronline.org 
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survival of RGCs after traumatic ON injury. In this study 
we examined dose-dependent and combined effects of 
MK-801 and nitro-L-arginine (L-NA) on RGC survival 
after ON transaction (Table 1). 
 
RESULTS  
 
Fluorogold-labeled RGCs and glial cells 
RGCs of all sizes were labeled with fluorogold. They had 
large oval somas and very few processes could be seen 
with the exception of the proximal part of some primary 
dendrites. Due to uptake of the dye from dead RGCs, 
fluorogold-labeled glial cells appeared in the retina 1 
week after ON transection. Glial cells had smaller somas 
and irregular cell borders, and their short and branched 
processes could be seen clearly. When RGC number 
decreased with the survival time, the number of glial cells 
increased (Figures 1 and 2).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surviving RGCs 
When compared with the mean numbers of Fluorogold- 
labeled surviving RGCs at 1 week in control group, no 
significant difference (P > 0.05) in the RGC number could 
be observed in 1.0 mg/kg MK-801 subgroup. Similar 
RGC numbers (P > 0.05) in 3.0 and 4.5 mg/kg MK-801 
subgroups were significantly higher (P = 0.001) than 
those in control group and 1.0 mg/kg MK-801 subgroup 
at 1 week (Figure 3). When survival time extended to   
2 weeks, the RGC numbers in 3.0 and 4.5 mg/kg 
subgroups remained significantly higher than those in  
1.0 mg/kg subgroup and control group (P < 0.001). The 
highest RGC numbers at 1 and 2 weeks were obtained in 
3.0 mg/kg MK-801 subgroup (Figure 4 and Table 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The RGC numbers were elevated with increased dosage 
of L-NA at 1 week. The highest RGC number in       
4.5 mg/kg L-NA subgroup was then followed by a slightly 
lower but similar RGC number in 6.0 mg/kg L-NA 
Figure 1  Microphotographs of Fluorogold-labeled 
surviving retinal ganglion cells 1 week after optic nerve 
transection in control (A), 1.0 mg/kg MK-801 (B),       
3.0 mg/kg MK-801(C), 4.5 mg/kg MK-801 (D), 1.5 mg/kg 
nitro-L-arginine (L-NA) (E), 3.0 mg/kg L-NA (F), 4.5 mg/kg 
L-NA (G), 6.0 mg/kg L-NA (H), combinational 1.0 mg/kg 
MK-801 and 1.5 mg/kg L-NA (I) groups. Retinal ganglion 
cells have large circular cell bodies with clear boundaries 
(arrow heads). A few glial cells with small irregular bodies 
and short branched-processes are also visible in the retina 
(arrows). Scale bar: 100 μm. 
Figure 2  Microphotographs of Fluorogold-labeled 
surviving retinal ganglion cells (arrow heads) 2 weeks after 
optic nerve transection in control (A), 1.0 mg/kg MK-801 
(B), 3.0 mg/kg MK-801(C), 4.5 mg/kg MK-801 (D),     
1.5 mg/kg nitro-L-arginine (L-NA) (E), 3.0 mg/kg L-NA (F), 
4.5 mg/kg L-NA (G), 6.0 mg/kg L-NA (H), combinational 
1.0 mg/kg MK-801 and 1.5 mg/kg L-NA (I) groups. A few 
glial cells with small irregular bodies and short branched 
processes are also visible in the retina (arrows). Scale bar:   
100 μm. 
Figure 3  The effect of MK-801 on the survival of 
axotomized retinal ganglion cells (RGCs) at 1 week after 
MK-801 injection. The number of surviving RGCs 
increased markedly when 3.0 mg/kg MK-801 was injected. 
Although the number of RGCs decreased slightly when 
the dosage of 4.5 mg/kg was given, the number of RGCs 
was still significantly higher than that in control and     
1.0 mg/kg MK-801-injected animals (aP < 0.001). The data 
are represented by mean ± SEM, and analyzed using 
one-way analysis of variance. 
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subgroup (P > 0.05). All these 4 numbers were 
significantly higher (P < 0.001) than those in control 
group (Figure 5). Although there was no significant 
difference (P > 0.05) in the RGC numbers between   
1.5 mg/kg L-NA subgroup and control group at 2 weeks, 
increased dosage of L-NA at 3.0, 4.5 and 6.0 mg/kg 
resulted in significantly higher RGC numbers           
(P = 0.000 1), with the highest RGC number also in   
4.5 mg/kg L-NA subgroup (Table1 and Figure 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The RGC numbers in combination group were 
significantly higher than those in control groups (P < 
0.001) at 1 and 2 weeks (Figure 7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When compared to those in 1.0 mg/kg MK-801 subgroup 
and 1.5 mg/kg L-NA subgroup at 1 week, significantly 
difference was only detected between combination group 
and 1.0 mg/kg MK-801 subgroup (P < 0.001). At 2 weeks, 
the RGC number in combination group was significantly 
higher (P = 0.000 4) than those in both 1.0 mg/kg 
MK-801 subgroup and 1.5 mg/kg L-NA subgroup. 
 
Figure 4  The effect of MK-801 on the survival of retinal 
ganglion cells (RGCs) at 2 weeks after MK-801 injection. 
The number of surviving RGCs was significantly increased 
with treatment of a higher dosage of 3.0 or 4.5 mg/kg 
when compared to that in control animals. The highest 
number of surviving RGCs was also obtained with daily 
injection of 3.0 mg/kg MK-801 for this time point (aP < 
0.001). The data are represented by mean ± SEM, and 
analyzed using one-way analysis of variance. 
Figure 5  The effect of nitro-L-arginine (L-NA) on the 
survival of retinal ganglion cells (RGCs) at 1 week after 
L-NA injection. The highest number of RGCs was found at 
4.5 mg/kg and all the RGCs numbers in the experimental 
subgroups were significantly higher than those in the 
control animals (aP < 0.001). The data are represented by 
mean ± SEM, and analyzed using one-way analysis of 
variance. 
Figure 6  The effect of nitro-L-arginine (L-NA) on the 
survival of retinal ganglion cells (RGCs) at 2 weeks after 
L-NA injection. There was no significant difference in the 
RGCs number between 1.5 mg/kg L-NA subgroup and 
control group. Increased dosages of L-NA at 3.0, 4.5 or  
6.0 mg/kg resulted in increased RGCs numbers with the 
highest number of RGCs also being at 4.5 mg/kg (aP < 
0.001). The data are represented by mean ± SEM, and 
analyzed using one-way analysis of variance. 
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Figure 7  The effect of combinational use of MK-801 and 
nitro-L-arginine on the retinal ganglion cells (RGCs) 
survival at 1 and 2 weeks after injecton. Significantly 
higher RGCs numbers were revealed in combination 
group at both time points (aP < 0.001). The data are 
represented by mean ± SEM, and analyzed using one-way 
analysis of variance. 
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Moreover, the effect of the combinational treatment of 
MK-801 and L-NA was potentiated in comparison with 
the added effects of MK-801 or L-NA alone because the 
RGC number in combination group at 2 weeks (5 900) 
was higher than the added number of 2 749 in 1.0 mg/kg 
MK-801 subgroup and 2 696 in 1.5 mg/kg L-NA subgroup 
(Figure 8 and Table 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examination of the right retina from hamsters of all 
groups indicated that daily injections of MK-801 and/or 
L-NA, and the long term labeling of the RGCs with 
fluorogold for at least 11 weeks did not affect the intact 
RGCs, and hence the results of the present study.  
 
DISCUSSION  
 
Neuronal production of NO is triggered when glutamate 
binds to and activates a NMDA receptor on an adjacent 
neuron. A channel in the receptor is therefore opened, 
admitting Ca
2+
 into the cell where it binds to calmodulin. 
The Ca
2+
/calmodulin complex then binds to and activates 
NOS so that, in the presence of oxygen and 
5,10-nicotinamide-adenine dinucleotide phosphate 
reductase, NOS converts L-arginine to L-citrulline and 
NO which is then released from the cell. It has been 
reported that NMDA-receptor blockade with the NMDA 
receptor antagonist MK-801 enhances cell apoptosis in 
the developing retina of the postnatal rat
[4]
 and a 
noncompetitive NMDA receptor antagonist, Bis(7)-tacrine, 
can prevent glutamate-induced rat RGCs damage in vitro 
and in vivo 
[9]
. However, MK-801 at 0-100 µM can not 
significantly attenuate the H2O2-induced cytotoxicity
[10]
. 
We have demonstrated in the present study that daily 
intraperitoneal injections of MK-801 increased neuronal 
survival of RGCs following ON transection in a 
dose-dependent manner. At both 1 and 2 weeks, the 
numbers of surviving RGCs were not promoted 
significantly with the treatment of 1.0 mg/kg MK-801 
when compared to control groups. However, RGC 
numbers increased significantly with a higher dosage of 
3.0 or 4.5 mg/kg. Both the highest RGC numbers at 1 
and 2 weeks were obtained with the treatment of MK-801 
at 3.0 mg/kg.   
It is also interesting that either increased or decreased 
NOS expression has been shown after neuronal 
injury
[11-16]
. NOS expression can also remain unchanged 
within the adult rodent retina up to 4 months following 
intraorbital ON transection
[11, 17]
.  The finding that 
lesion-induced NOS within injured neurons is coincident 
with death of these neurons which suggests a role of NO 
in neuronal degeneration. If NO, produced by 
lesion-induced NOS, is responsible for the death of 
injured neurons, inhibition of NOS should therefore 
prevent the death of these neurons. However, although 
this hypothesis has been widely supported by a large 
number of studies using NOS inhibitors
[18-19]
, the effects 
of NO on neuronal survival can be either protective or 
destructive
[18]
. Such paradoxical phenomena may 
probably be interpreted as differences in distinct 
response to axonal injury among NOS-containing neuron 
groups. In two main lines of investigations, NOS 
expression is markedly augmented in spinal neurons 
after spinal root avulsion
[20-21]
 or spinal cord transection
[21]
 
and in the hypothalamic supraoptic nuclei and 
paraventricular following hypophysectomy
[19, 22]
. Inhibition 
of NOS protected RGCs against glaucomatous 
damage
[14]
.
 
L-N(6)-(1-iminoethyl)lysine 5-tetrazole amide, 
a prodrug of a selective inhibitor of inducible NOS, 
prevented the loss of retinal ganglion cells in eyes with 
chronic, moderately elevated intraocular pressure in an 
animal model of glaucoma
[13]
. Daily intraperitoneal 
injection of L-NA in the present study also retarded the 
degeneration of axotomized RGCs in a dose-dependent 
fashion. This protective effect may be achieved by the 
inhibition of NO production in adjacent amacrine cells 
with L-NA.  
Table 1  Numbers of Fluorogold-labeled retinal ganglion 
cells at two different survival time points in all control and 
experimental groups 
Group 
Survival time (week) 
1 2 
Normal without optic nerve cut 76 810±3 644 
Control with optic nerve cut 16 121±1 263 1 296±367 
1.0 mg/kg MK-801 treatment 19 444±1 718 2 749±504 
3.0 mg/kg MK-801 treatment 30 145±496 6 107±412 
4.5 mg/kg MK-801 treatment 26 065±1 595 4 189±674 
1.5 mg/kg L-NA treatment 24 325±1 624 2 713±412 
3.0 mg/kg L-NA treatment 29 531±2 419 4 406±529 
4.5 mg/kg L-NA treatment 35 769±2 503 5 287±381 
6.0 mg/kg L-NA treatment 31 843±2 420 3 445±238 
Combinational use of 1.0 mg/kg  
MK-801 and 1.5 mg/kg L-NA 
27 319±1927 5 900±959 
 
Figure 8  The effect of MK-801, nitro-L-arginine (L-NA) 
alone or their combination on the retinal ganglion cells 
(RGCs) survival at 1 and 2 weeks. The RGCs numbers in 
combination group at both time points were significantly 
higher than those in 1.0 mg/kg MK-801 and 1.5 mg/kg 
L-NA subgroups (aP < 0.001). The data are represented by 
mean ± SEM, and analyzed using one-way analysis of 
variance. 
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In this experiment, RGC loss after ON transection was 
reduced, but not completely prevented, by NMDA 
receptor antagonist and NOS inhibitor. There are several 
explanations for this incomplete neuroprotective effect of 
NOS inhibitors: (1) the lesion-induced NOS was not 
completely inhibited by MK-801 and L-NA at the dose 
level used; (2) lesion was not the only stimulus to induce 
NOS/NO responsible for the death of injured RGCs;    
(3) the neurotoxicity of glutamate could not be overcome 
completely with MK-801; the antagonist of the NMDA 
subtype of glutamate receptors, as it has been reported 
recently that low doses of glutamate can activate 
α-amino-3-digydro-5-methyl-isoxazol-4-propionic 
acid-kainate receptors in cultured RGCs, which causes 
increases in intracellular calcium and decreases in cell 
survival
[23]
. Also, there might be other than NMDA and 
NOS death mechanisms activated after ON transection. 
The mechanisms for the protective effects of these NOS 
inhibitors might be both indirect, reducing the production 
of NO which is synthesized in and released from 
adjacent amacrine cells in either the inner nuclear layer 
or the ganglion cell layer, and direct, blocking the 
neurotoxicity of glutamate with MK-801 on injured RGCs.  
We have also shown that combinational injections of  
1.0 mg/kg MK-801 and 1.5 mg/kg L-NA, neither of the 
dosages are the optimal ones, enhanced the survival of 
RGCs 1 and 2 weeks after ON transection, suggesting 
the potentiative action of these two chemicals, which 
influence different phases of NO biosynthesis on the 
same biochemical pathway, on the survival of 
axotomized RGCs. NO synthesis can be inhibited by 
MK-801 as a NMDA antagonist or L-NA as a competitive 
NOS inhibitor, thus inhibiting NOS more effectively.  
Our findings indicated that both MK-801 and L-NA can 
protect axotomized RGCs in a dose-dependent manner 
and combinational treatment of these two chemicals 
possesses a potentiative and protective effect. 
 
MATERIALS AND METHODS 
 
Design 
A randomized controlled animal experiment. 
Time and setting 
This study was conducted in the Department of Anatomy, 
Li Ka Shing Faculty of Medicine, The University of Hong 
Kong and Institute of Neurosciences, the Fourth Military 
Medical University from February to December, 2011. 
Materials 
One hundred and fourteen adult male hamsters of    
6-7 weeks old (Mesocricetus auratus, the Laboratory 
Animal Units of the University of Hong Kong and the 
Fourth Military Medical University) were divided into one 
control and three experimental groups (MK-801, L-NA 
and combination groups). 
Methods 
Pre-labeling of RGCs and ON transection 
All animals were anesthetized with an intraperitoneal 
injection of sodium pentobarbital (60 mg/kg body weight; 
Ovation Pharmaceuticals, USA) for all surgical 
procedures. The RGCs of the animals were retrogradely 
labeled by applying small pieces of Gelfoam (Upjohn, 
USA) soaked in 5% fluorogold (Fluorochrome, USA) onto 
the surfaces of bilateral superior colliculi after the cortical 
tissues and pia overlying the superior colliculi was 
carefully removed. Six animals in control group were 
allowed to survive for 4 days after pre-labeling without 
ON transection. The left ONs of all other 108 animals 
were exposed 4 days later through a superior temporal 
intraorbital approach and transected intraorbitally 1 mm 
from the optic disc under an operating microscope 
(Olympus OME, Japan). Care was taken to avoid any 
damages to retinal blood supply from the ophthalmic 
artery
[24]
. 
Treatments 
One day before the left ON transection, 84 animals 
received intraperitoneal injections of different dosages of 
MK-801 (1.0, 3.0 or 4.5 mg/kg; ICN Pharmaceuricals, 
USA) and L-NA (1.5, 3.0, 4.5 or 6.0 mg/kg; Aldrich, USA) 
in sterile saline in MK-801 and L-NA groups (n = 12 for 
each dosage) and survived for 1 or 2 weeks (n = 6 for 
each time point). Another 12 animals in combination 
group received daily intraperitoneal injections of 
combinational 1.0 mg/kg MK-801 and 1.5 mg/kg L-NA 
until the animals were killed 1 or 2 weeks following ON 
transection (n = 6 for each time point). Another 12 control 
animals received IP injections of the same volume of 
saline before they were killed 1 or 2 weeks after ON 
transection (n = 6 for each time point). 
Counting of Fluorogold-labeled surviving RGCs 
All animals were sacrificed with an overdose (100 mg/kg 
body weight) of anesthesia at the appropriate survival 
time. The left retinas were removed, post-fixed in 4% 
paraformaldehyde (Merck, Germany) in PBS (0.1 M, pH 
7.4) for 1 hour, rinsed in PBS (0.1 M, pH 7.4) for 3 times, 
divided into superionasal, superiotemporal, inferionasal 
and inferiotemporal quadrants with four radial cuts 
(Figure 9), flat-mounted on gelatin-coated slides in 30% 
glycerol (Merck, Germany) and eventually coverslipped.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9  The schematic diagram showing the same 
sampling areas along the four quadrants of the retina. 
Superiotemporal Superionasal 
Inferiotemporal Inferionasal 
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The total populations of Fluorogold-labeled surviving 
RGCs in the retinas were estimated using a sampling 
technique
[25]
. In each retina, the number of RGCs was 
counted in 28-30 sample areas (each occupying 40 000 µm2) 
at 7 to 8 different eccentricities from the optic disc in four 
different quadrants of the retina under a BX51 
fluorescence microscope (Olympus, Japan) using a 
355-425 nm ultraviolet filter. The data from all sample 
areas were pooled and the total number of RGCs 
counted was divided by the areas sampled, thus 
obtaining the estimated mean density of surviving RGCs. 
Finally, the estimated number of surviving RGCs in each 
retina was calculated by multiplying the mean density of 
RGCs with the area of the retina. 
Statistical Analysis 
One-way analysis of variance was used to compare the 
mean numbers of surviving RGCs using SPSS (Version 
11.0, USA). All data values were presented as Mean ± 
SEM and differences were considered significant when  
P < 0.05. 
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